N-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide

C100H106N22O6 — CID 160813131

IUPACN-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide
SMILESO=C(NC1CCCCC1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12.O=C(NCc1cccnc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12.O=C(Nc1ccc2c(c1)OCO2)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12.O=C(Nc1ccncc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12
InChIInChI=1S/C26H25N5O3.C25H26N6O.C25H31N5O.C24H24N6O/c32-26(28-20-5-7-23-24(12-20)34-16-33-23)25-21-11-18(4-6-22(21)29-30-25)19-10-17(13-27-14-19)15-31-8-2-1-3-9-31;32-25(28-15-18-5-4-8-26-13-18)24-22-12-20(6-7-23(22)29-30-24)21-11-19(14-27-16-21)17-31-9-2-1-3-10-31;31-25(27-21-7-3-1-4-8-21)24-22-14-19(9-10-23(22)28-29-24)20-13-18(15-26-16-20)17-30-11-5-2-6-12-30;31-24(27-20-6-8-25-9-7-20)23-21-13-18(4-5-22(21)28-29-23)19-12-17(14-26-15-19)16-30-10-2-1-3-11-30/h4-7,10-14H,1-3,8-9,15-16H2,(H,28,32)(H,29,30);4-8,11-14,16H,1-3,9-10,15,17H2,(H,28,32)(H,29,30);9-10,13-16,21H,1-8,11-12,17H2,(H,27,31)(H,28,29);4-9,12-15H,1-3,10-11,16H2,(H,28,29)(H,25,27,31)
InChIKeySEODZQLBUWYBCL-UHFFFAOYSA-N
MW1712.10 g/mol
LogP17.46
Rot. Bonds21

About N-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide

N-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide (PubChem CID 160813131) has the molecular formula C100H106N22O6 and a molecular weight of 1712.10 g/mol. Its IUPAC name is N-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide.

Molecular Properties

Compound NameN-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide
PubChem CID160813131
Molecular FormulaC100H106N22O6
Molecular Weight1712.10 g/mol
Exact Mass1710.87
IUPAC NameN-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide
SMILESO=C(NC1CCCCC1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12.O=C(NCc1cccnc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12.O=C(Nc1ccc2c(c1)OCO2)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12.O=C(Nc1ccncc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12
InChIInChI=1S/C26H25N5O3.C25H26N6O.C25H31N5O.C24H24N6O/c32-26(28-20-5-7-23-24(12-20)34-16-33-23)25-21-11-18(4-6-22(21)29-30-25)19-10-17(13-27-14-19)15-31-8-2-1-3-9-31;32-25(28-15-18-5-4-8-26-13-18)24-22-12-20(6-7-23(22)29-30-24)21-11-19(14-27-16-21)17-31-9-2-1-3-10-31;31-25(27-21-7-3-1-4-8-21)24-22-14-19(9-10-23(22)28-29-24)20-13-18(15-26-16-20)17-30-11-5-2-6-12-30;31-24(27-20-6-8-25-9-7-20)23-21-13-18(4-5-22(21)28-29-23)19-12-17(14-26-15-19)16-30-10-2-1-3-11-30/h4-7,10-14H,1-3,8-9,15-16H2,(H,28,32)(H,29,30);4-8,11-14,16H,1-3,9-10,15,17H2,(H,28,32)(H,29,30);9-10,13-16,21H,1-8,11-12,17H2,(H,27,31)(H,28,29);4-9,12-15H,1-3,10-11,16H2,(H,28,29)(H,25,27,31)
InChIKeySEODZQLBUWYBCL-UHFFFAOYSA-N
XLogP17.46
TPSA339.88 Ų
H-Bond Donors8
H-Bond Acceptors20
Rotatable Bonds21
Heavy Atoms128
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001712.10
LogP ≤ 517.46
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1020

Analyze N-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide?
The IUPAC name of N-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide (CID 160813131) is N-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide.
What is the SMILES notation for N-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide?
The canonical SMILES for N-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide is O=C(NC1CCCCC1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12.O=C(NCc1cccnc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12.O=C(Nc1ccc2c(c1)OCO2)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12.O=C(Nc1ccncc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12.
What is the InChIKey of N-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide?
The InChIKey is SEODZQLBUWYBCL-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H25N5O3.C25H26N6O.C25H31N5O.C24H24N6O/c32-26(28-20-5-7-23-24(12-20)34-16-33-23)25-21-11-18(4-6-22(21)29-30-25)19-10-17(13-27-14-19)15-31-8-2-1-3-9-31;32-25(28-15-18-5-4-8-26-13-18)24-22-12-20(6-7-23(22)29-30-24)21-11-19(14-27-16-21)17-31-9-2-1-3-10-31;31-25(27-21-7-3-1-4-8-21)24-22-14-19(9-10-23(22)28-29-24)20-13-18(15-26-16-20)17-30-11-5-2-6-12-30;31-24(27-20-6-8-25-9-7-20)23-21-13-18(4-5-22(21)28-29-23)19-12-17(14-26-15-19)16-30-10-2-1-3-11-30/h4-7,10-14H,1-3,8-9,15-16H2,(H,28,32)(H,29,30);4-8,11-14,16H,1-3,9-10,15,17H2,(H,28,32)(H,29,30);9-10,13-16,21H,1-8,11-12,17H2,(H,27,31)(H,28,29);4-9,12-15H,1-3,10-11,16H2,(H,28,29)(H,25,27,31).
What are the key properties of N-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide?
N-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide has a molecular weight of 1712.10 g/mol, XLogP of 17.46, 21 rotatable bonds, 8 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1,3-benzodioxol-5-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-cyclohexyl-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-pyridin-4-yl-1H-indazole-3-carboxamide;5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-N-(pyridin-3-ylmethyl)-1H-indazole-3-carboxamide is sourced from PubChem (CID 160813131), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).